Catatan efek · kuartal yang diarsipkan
AZN
AstraZeneca PLC · Healthcare · Drug Manufacturers - General
20Pemegang yang dilacak
—Δ pemegang
172.48MSaham yang dipegang
$13.45BNilai yang dilaporkan
+0Posisi baru
−0Keluar
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 156 | +6 | 601.54M | $113.17B | +11 | −4 |
| Q1 2026 | 151 | +2 | 571.10M | $111.81B | +21 | −20 |
| Q4 2025 | 148 | 0 | 438.95M | $40.35B | +2 | −1 |
| Q3 2025 | 24 | 0 | 219.30M | $16.82B | +1 | −2 |
| Q2 2025 | 22 | -1 | 189.68M | $13.26B | — | −1 |
| Q1 2025 | 21 | 0 | 171.06M | $12.57B | — | — |
| Q4 2024 | 21 | +3 | 174.28M | $11.42B | +3 | — |
| Q3 2024 | 17 | -3 | 166.39M | $12.97B | — | −3 |
| Q2 2024 | 20 | — | 172.48M | $13.45B | — | — |
Siapa yang memegangnya · Q2 2024
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 64.94M | — | $5.06B | 0.6% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 64.94M | — | $5.06B | 0.6% | n/c | 1 | SEC ↗ |
| 3 | PRIMECAP Management ✦ | 42.60M | — | $3.32B | 2.4% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 9.96M | — | $776.47M | 0.3% | n/c | 1 | SEC ↗ |
| 13 | Capital World Investors ✦ | 6.25M | — | $487.65M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Soros Fund Management ✦ | 2.45M | — | $191.20M | 5.9% | n/c | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 2.29M | — | $178.48M | 0.4% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 617.71K | — | $48.17M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 617.71K | — | $48.17M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 587.36K | — | $45.81M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 498.95K | — | $38.91M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Geode Capital Management ✦ (pasif) | 492.18K | — | $38.38M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 346.47K | — | $27.02M | 0.1% | n/c | 1 | SEC ↗ |
| 22 | Arrowstreet Capital ✦ | 261.33K | — | $20.38M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 209.18K | — | $16.31M | 0.1% | n/c | 1 | SEC ↗ |
| 24 | Dodge & Cox ✦ | 149.78K | — | $11.68M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Norges Bank ✦ (pasif) | 120.79K | — | $9.42M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Renaissance Technologies ✦ | 57.50K | — | $4.48M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 33.35K | — | $2.60M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Millennium Management ✦ | 32.65K | — | $2.55M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 13.69K | — | $1.07M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 13.69K | — | $1.07M | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 2 pemegang, 42.58K saham, $8.26M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q2 2024 ·
Metodologi ·
Dapatkan ini melalui API